These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37695454)

  • 1. Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab).
    Roshani A; Mohammadi M; Bahadori T; Ahmadi Zare H; Judaki MA; Mobini M; Golsaz-Shirazi F; Jeddi-Tehrani M; Amiri MM; Shokri F
    Daru; 2023 Dec; 31(2):221-231. PubMed ID: 37695454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.
    Jain NK; Barkowski-Clark S; Altman R; Johnson K; Sun F; Zmuda J; Liu CY; Kita A; Schulz R; Neill A; Ballinger R; Patel R; Liu J; Mpanda A; Huta B; Chiou H; Voegtli W; Panavas T
    Protein Expr Purif; 2017 Jun; 134():38-46. PubMed ID: 28342833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.
    Rajendra Y; Hougland MD; Alam R; Morehead TA; Barnard GC
    Biotechnol Bioeng; 2015 May; 112(5):977-86. PubMed ID: 25502369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A BioDesign Approach to Obtain High Yields of Biosimilars by Anti-apoptotic Cell Engineering: a Case Study to Increase the Production Yield of Anti-TNF Alpha Producing Recombinant CHO Cells.
    Gulce Iz S; Inevi MA; Metiner PS; Tamis DA; Kisbet N
    Appl Biochem Biotechnol; 2018 Jan; 184(1):303-322. PubMed ID: 28685239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-Scale Transient Production in ExpiCHO-S™ with Enhanced N-Galactosylation-Sialylation and PEI-Based Transfection.
    Zhong X; Schwab A; Ma W; Meade CL; Zhou J; D'Antona AM; Somers W; Lin L
    Methods Mol Biol; 2022; 2313():143-150. PubMed ID: 34478135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.
    Zhong X; Ma W; Meade CL; Tam AS; Llewellyn E; Cornell R; Cote K; Scarcelli JJ; Marshall JK; Tzvetkova B; Figueroa B; DiNino D; Sievers A; Lee C; Guo J; Mahan E; Francis C; Lam K; D'Antona AM; Zollner R; Zhu HL; Kriz R; Somers W; Lin L
    Biotechnol Prog; 2019 Jan; 35(1):e2724. PubMed ID: 30299005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional and post-transcriptional limitations of high-yielding, PEI-mediated transient transfection with CHO and HEK-293E cells.
    Rajendra Y; Kiseljak D; Baldi L; Wurm FM; Hacker DL
    Biotechnol Prog; 2015; 31(2):541-9. PubMed ID: 25683738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level protein expression in scalable CHO transient transfection.
    Ye J; Kober V; Tellers M; Naji Z; Salmon P; Markusen JF
    Biotechnol Bioeng; 2009 Jun; 103(3):542-51. PubMed ID: 19199356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.
    Amiri MM; Golsaz-Shirazi F; Soltantoyeh T; Hosseini-Ghatar R; Bahadori T; Khoshnoodi J; Navabi SS; Farid S; Karimi-Jafari MH; Jeddi-Tehrani M; Shokri F
    Invest New Drugs; 2018 Apr; 36(2):171-186. PubMed ID: 28983766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Experiment in CHO and HEK transient transfection condition optimization.
    Bollin F; Dechavanne V; Chevalet L
    Protein Expr Purif; 2011 Jul; 78(1):61-8. PubMed ID: 21354312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L).
    Majors BS; Betenbaugh MJ; Pederson NE; Chiang GG
    Biotechnol Bioeng; 2008 Oct; 101(3):567-78. PubMed ID: 18727128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of a transient antibody expression platform towards high titer and efficiency.
    Greene E; Cazacu D; Tamot N; Castellano S; Datar A; Kronkaitis A; Gebhard D; Reed J; Mawson P; Florin L; Rossi N; Lauer A; Juckem L; Nixon A; Wenger T; Sen S
    Biotechnol J; 2021 Apr; 16(4):e2000251. PubMed ID: 33226178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple high-yielding process for transient gene expression in CHO cells.
    Rajendra Y; Kiseljak D; Baldi L; Hacker DL; Wurm FM
    J Biotechnol; 2011 Apr; 153(1-2):22-6. PubMed ID: 21392548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-amplification of EBNA-1 and PyLT through dhfr-mediated gene amplification for improving foreign protein production in transient gene expression in CHO cells.
    Lee JH; Park JH; Park SH; Kim SH; Kim JY; Min JK; Lee GM; Kim YG
    Appl Microbiol Biotechnol; 2018 Jun; 102(11):4729-4739. PubMed ID: 29654557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring cellular behavior under transient gene expression and its impact on mAb productivity and Fc-glycosylation.
    Sou SN; Lee K; Nayyar K; Polizzi KM; Sellick C; Kontoravdi C
    Biotechnol Bioeng; 2018 Feb; 115(2):512-518. PubMed ID: 28921534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHO-S antibody titers >1 gram/liter using flow electroporation-mediated transient gene expression followed by rapid migration to high-yield stable cell lines.
    Steger K; Brady J; Wang W; Duskin M; Donato K; Peshwa M
    J Biomol Screen; 2015 Apr; 20(4):545-51. PubMed ID: 25520372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild hypothermia improves transient gene expression yields several fold in Chinese hamster ovary cells.
    Wulhfard S; Tissot S; Bouchet S; Cevey J; De Jesus M; Hacker DL; Wurm FM
    Biotechnol Prog; 2008; 24(2):458-65. PubMed ID: 18220408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells.
    Schlatter S; Stansfield SH; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2005; 21(1):122-33. PubMed ID: 15903249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.